HIN 0.00% $2.37 heartware international, inc

the possible game changer

  1. 998 Posts.
    lightbulb Created with Sketch. 12

    of 618





    HTWR gives $149k Grant to Clev-Clin. researcher K.Fukamachi for MVAD studies. (not sure when it was awarded - newsletter dated Dec. 2012)...

    Kiyotaka Fukamachi, MD, PhD, Biomedical Engineering, received a 1-year, $149K award from HeartWare, Inc. (Framingham, MA), for "Acute evaluation of HeartWare MVAD in a pacing-induced heart failure model in sheep." Nader Moazami, MD, Thoracic and Cardiovascular Surgery, is a co-investigator on the study.

    This research evaluates the performance of a miniaturized left ventricular assist device (about one third the size of the company's device for humans) in an animal model. The tiny device may one day allow surgeons to implant it under minimally invasive procedures in people, avoiding the risks to the patient of full "rib-cracking" (median sternotomy) surgery.

    Interesting!!
 
watchlist Created with Sketch. Add HIN (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.